Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.14 USD | +25.43% | +24.15% | -8.04% |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.04% | 191M | |
+30.04% | 454B | |
+27.08% | 264B | |
+7.50% | 136B | |
+34.35% | 95.88B | |
+7.13% | 93.13B | |
+60.44% | 57.75B | |
+17.21% | 46.89B | |
+27.88% | 38.33B | |
+1.36% | 35.84B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- RBC Cuts Price Target on OptimizeRx to $22 From $50, Maintains Outperform Rating